ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
17 06 2021
Historique:
received: 11 10 2020
revised: 30 01 2021
accepted: 01 02 2021
pubmed: 19 2 2021
medline: 29 3 2022
entrez: 18 2 2021
Statut: ppublish

Résumé

Synaptic dysfunction and cognitive decline in Huntington's disease (HD) involve hyperactive A disintegrin and metalloproteinase domain-containing protein 10 (ADAM10). To identify the molecular mechanisms through which ADAM10 is associated with synaptic dysfunction in HD, we performed an immunoaffinity purification-mass spectrometry (IP-MS) study of endogenous ADAM10 in the brains of wild-type and HD mice. We found that proteins implicated in synapse organization, synaptic plasticity, and vesicle and organelles trafficking interact with ADAM10, suggesting that it may act as hub protein at the excitatory synapse. Importantly, the ADAM10 interactome is enriched in presynaptic proteins and ADAM10 co-immunoprecipitates with piccolo (PCLO), a key player in the recycling and maintenance of synaptic vesicles. In contrast, reduced ADAM10/PCLO immunoprecipitation occurs in the HD brain, with decreased density of synaptic vesicles in the reserve and docked pools at the HD presynaptic terminal. Conditional heterozygous deletion of ADAM10 in the forebrain of HD mice reduces active ADAM10 to wild-type level and normalizes ADAM10/PCLO complex formation and synaptic vesicle density and distribution. The results indicate that presynaptic ADAM10 and PCLO are a relevant component of HD pathogenesis.

Identifiants

pubmed: 33601422
pii: 6144550
doi: 10.1093/hmg/ddab047
doi:

Substances chimiques

Cytoskeletal Proteins 0
Neuropeptides 0
Pclo protein, mouse 0
ADAM10 Protein EC 3.4.24.81

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1175-1187

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Auteurs

Flora Cozzolino (F)

Department of Chemical Sciences, University of Naples "Federico II", Naples 80126, Italy.
CEINGE Advanced Biotechnologies, Naples 80131, Italy.

Elena Vezzoli (E)

Department of Biomedical Sciences for Health, University of Milan, Milan 20133, Italy.

Cristina Cheroni (C)

European Institute of Oncology, IRCCS, Milan 20141, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.

Dario Besusso (D)

Department of Biosciences, University of Milan, Milan 20133, Italy.
Istituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan 20122, Italy.

Paola Conforti (P)

Department of Biosciences, University of Milan, Milan 20133, Italy.
Istituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan 20122, Italy.

Marta Valenza (M)

Department of Biosciences, University of Milan, Milan 20133, Italy.
Istituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan 20122, Italy.

Ilaria Iacobucci (I)

Department of Chemical Sciences, University of Naples "Federico II", Naples 80126, Italy.
CEINGE Advanced Biotechnologies, Naples 80131, Italy.

Vittoria Monaco (V)

CEINGE Advanced Biotechnologies, Naples 80131, Italy.
Biostructures and Biosystems National Institute (INBB), Rome 00136, Italy.

Giulia Birolini (G)

Department of Biosciences, University of Milan, Milan 20133, Italy.
Istituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan 20122, Italy.

Mauro Bombaci (M)

Istituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan 20122, Italy.

Andrea Falqui (A)

Biological and Environmental Science and Engineering (BESE) Division, NABLA Lab, King Abdullah University of Science and Technology (KAUST), Thuwal 23955, Saudi Arabia.

Paul Saftig (P)

Institute of Biochemistry, Christian-Albrechts-University of Kiel, Kiel D-24098, Germany.

Riccardo L Rossi (RL)

Istituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan 20122, Italy.

Maria Monti (M)

Department of Chemical Sciences, University of Naples "Federico II", Naples 80126, Italy.
CEINGE Advanced Biotechnologies, Naples 80131, Italy.

Elena Cattaneo (E)

Department of Biosciences, University of Milan, Milan 20133, Italy.
Istituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan 20122, Italy.

Chiara Zuccato (C)

Department of Biosciences, University of Milan, Milan 20133, Italy.
Istituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan 20122, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH